{
  "id": 459,
  "text": "2 \\%$ and $1 0 .9 \\%$ of patients with cervical intraepithelial neoplasia (CIN) I-III at the conisation resection margin had residual CIN I-III and invasive cancer in the repeat conisation/hysterectomy specimen, respectively.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: 2 \\%$ and $1 0 .9 \\%$ of patients with cervical intraepithelial neoplasia (CIN) I-III at the conisation resection margin had residual CIN I-III and invasive cancer in the repeat conisation/hysterectomy specimen, respectively.\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "根据临床数据，在第一次锥切手术后，约有2%的患者在锥切切缘仍留有宫颈上皮内瘤变（CIN）I-III，而10.9%的患者在重复锥切或子宫切除术标本中发现残留的CIN I-III或浸润性癌。这表明对于部分患者，初次锥切可能未能完全清除病变组织，因此术后监测与后续治疗尤为重要。",
  "query": "在进行第一次锥切手术后，哪些比例的患者在重复锥切或子宫切除术标本中仍然发现宫颈上皮内瘤变（CIN）I-III或浸润性癌？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在进行第一次锥切手术后，哪些比例的患者在重复锥切或子宫切除术标本中仍然发现宫颈上皮内瘤变（CIN）I-III或浸润性癌？\n\n<reference text>: 2 \\%$ and $1 0 .9 \\%$ of patients with cervical intraepithelial neoplasia (CIN) I-III at the conisation resection margin had residual CIN I-III and invasive cancer in the repeat conisation/hysterectomy specimen, respectively.\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "根据临床数据，在第一次锥切手术后，约有2%的患者在锥切切缘仍留有宫颈上皮内瘤变（CIN）I-III，而10.9%的患者在重复锥切或子宫切除术标本中发现残留的CIN I-III或浸润性癌。这表明对于部分患者，初次锥切可能未能完全清除病变组织，因此术后监测与后续治疗尤为重要。"
}